These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of an Kimura H; Fujita N; Kanbe K; Matsuda H; Watanabe H; Arimitsu K; Fujimoto H; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H Bioorg Med Chem; 2017 Oct; 25(20):5772-5778. PubMed ID: 28927802 [TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a. Burvenich IJ; Parakh S; Gan HK; Lee FT; Guo N; Rigopoulos A; Lee ST; Gong S; O'Keefe GJ; Tochon-Danguy H; Kotsuma M; Hasegawa J; Senaldi G; Scott AM J Nucl Med; 2016 Jun; 57(6):974-80. PubMed ID: 26940768 [TBL] [Abstract][Full Text] [Related]
6. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor. Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel EphA2-targeting radioligand for SPECT imaging in different tumor models. Wang L; Zhang H; Huang W; Han Z; Xu H; Gu Y Eur J Med Chem; 2024 Feb; 265():116105. PubMed ID: 38154255 [TBL] [Abstract][Full Text] [Related]
9. 111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin. Cornelissen B; Waller A; Target C; Kersemans V; Smart S; Vallis KA EJNMMI Res; 2012 Feb; 2():9. PubMed ID: 22348532 [TBL] [Abstract][Full Text] [Related]
10. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer. Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460 [TBL] [Abstract][Full Text] [Related]
11. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007 [TBL] [Abstract][Full Text] [Related]
12. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Cai W; Ebrahimnejad A; Chen K; Cao Q; Li ZB; Tice DA; Chen X Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2024-36. PubMed ID: 17673999 [TBL] [Abstract][Full Text] [Related]
13. Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [ Chan C; Prozzo V; Aghevlian S; Reilly RM EJNMMI Radiopharm Chem; 2022 Dec; 7(1):33. PubMed ID: 36542157 [TBL] [Abstract][Full Text] [Related]
14. EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study. Puttick S; Stringer BW; Day BW; Bruce ZC; Ensbey KS; Mardon K; Cowin GJ; Thurecht KJ; Whittaker AK; Fay M; Boyd AW; Rose S Mol Imaging; 2015; 14():385-99. PubMed ID: 26218510 [TBL] [Abstract][Full Text] [Related]
15. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody. Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882 [TBL] [Abstract][Full Text] [Related]
16. SPECT imaging of colorectal cancer by targeting CD 133 receptor with 99mTc-labeled monoclonal antibody. Liu Y; Jin X; Lan X; Lang J; Wen Q; An R Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):216-224. PubMed ID: 27387378 [TBL] [Abstract][Full Text] [Related]
17. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment. Chang FL; Tsai KC; Lin TY; Chiang CW; Pan SL; Lee YC Heliyon; 2023 Nov; 9(11):e21774. PubMed ID: 38034633 [TBL] [Abstract][Full Text] [Related]
19. Development of Gold Nanorods Conjugated with Radiolabeled Anti-human Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody as Single-Photon Emission Computed Tomography/Photoacoustic Dual-Imaging Probes Targeting HER2-Positive Tumors. Ding N; Sano K; Shimizu Y; Watanabe H; Namita T; Shiina T; Ono M; Saji H Biol Pharm Bull; 2020; 43(12):1859-1866. PubMed ID: 33268703 [TBL] [Abstract][Full Text] [Related]